Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
The antiserum was produced against synthesized phosphopeptide derived from human CDK2 around the phosphorylation site of threonine 160 (T-Y-TP-H-E).
Modification:
p Thr160
Species Reactivity:
Human, Mouse, Rat
Applications:
Uses:
ELISA, Western Blot and Immunohistochemistry-Paraffin
Dilutions:
ELISA 1:4000, Immunohistochemistry-Paraffin 1:50-1:100, Western Blot 1:500-1:1000
Unit Size:
0.05 mg
Concentration:
1.0 mg/ml
Packaging:
Storage:
Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Buffer:
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, and 50% glycerol.
Preservative:
0.02% Sodium Azide
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Cdk2 is a member of the Ser/Thr protein kinase family. It is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent protein kinase complex, whose activity is restricted to the G1-S phase, and is essential for cell cycle G1/S phase transition. This protein associates with and is regulated by the regulatory subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Its activity is also regulated by protein phosphorylation. Two alternatively spliced variants and multiple transcription initiation sites of this gene have been reported.
Western Blot: CDK2 Phosphospecific Antibody [NB100-81843] - Western blot analysis of extracts from A2780 cells (Lane 1 and 2) and MDA-MB-435 cells (Lane 3), using CDK2 (phospho-Thr160) antibody
Immunohistochemistry: CDK2 Phosphospecific Antibody [NB100-81843] - Immunohistochemical analysis of paraffin- embedded human breast carcinoma tissue, using CDK2 (phospho-Thr160) antibody
Ukomadu C, et al.(2003) J Biol Chem; 278(7): 4840-6 Morris MC, et al.(2002)J Biol Chem; 277(26): 23847-53 Brown NR, et al.(1999)J Biol Chem; 274(13): 8746-56 Liu Y, et al.(2004) J Biol Chem; 279(6): 4507-14